Schroder Investment Management Group lessened its stake in shares of Envision Healthcare Corp (NYSE:EVHC) by 35.0% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 56,400 shares of the company’s stock after selling 30,400 shares during the quarter. Schroder Investment Management Group’s holdings in Envision Healthcare were worth $2,580,000 at the end of the most recent quarter.
Other large investors also recently added to or reduced their stakes in the company. Cerebellum GP LLC purchased a new stake in shares of Envision Healthcare during the third quarter valued at approximately $183,000. Acadian Asset Management LLC purchased a new stake in shares of Envision Healthcare during the second quarter valued at approximately $190,000. Liberty Mutual Group Asset Management Inc. bought a new position in shares of Envision Healthcare during the second quarter valued at approximately $213,000. Mint Tower Capital Management B.V. bought a new position in shares of Envision Healthcare during the second quarter valued at approximately $220,000. Finally, Alps Advisors Inc. bought a new position in shares of Envision Healthcare during the second quarter valued at approximately $235,000.
Shares of Envision Healthcare stock opened at $45.99 on Friday. Envision Healthcare Corp has a 52 week low of $23.77 and a 52 week high of $46.00.
A number of equities analysts recently commented on EVHC shares. Zacks Investment Research upgraded Envision Healthcare from a “hold” rating to a “buy” rating and set a $51.00 target price for the company in a report on Friday, September 7th. ValuEngine upgraded Envision Healthcare from a “strong sell” rating to a “sell” rating in a report on Monday, September 17th. Finally, Cantor Fitzgerald restated a “hold” rating and set a $46.00 target price on shares of Envision Healthcare in a report on Friday, August 10th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the stock. Envision Healthcare presently has a consensus rating of “Hold” and a consensus target price of $44.46.
ILLEGAL ACTIVITY WARNING: This piece was posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2018/12/08/schroder-investment-management-group-has-2-58-million-stake-in-envision-healthcare-corp-evhc.html.
Envision Healthcare Profile
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.
Read More: Diversification
Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Corp (NYSE:EVHC).
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.